Key Takeaways
- Amgen announced a $900 million expansion of its Ohio manufacturing facility, creating 750 jobs.
- The total investment in Central Ohio by Amgen has now surpassed $1.4 billion.
- CEO Robert Bradway emphasized Ohio’s supportive business climate and skilled workforce as key factors in the decision.
Expansion of Manufacturing in Ohio
US biotech leader Amgen (Nasdaq: AMGN) is significantly boosting its presence in the U.S. with a recent announcement of a $900 million expansion of its manufacturing facility in Ohio. This investment will create an additional 750 jobs, contributing to a total investment in Central Ohio that now exceeds $1.4 billion.
Since its establishment in 1988, Amgen has been a front-runner in the production of biologic medicines in the United States. Robert Bradway, the company’s chairman and CEO, discussed the significance of the expansion, stating, “Today’s investment reinforces our ongoing commitment to expanding U.S. manufacturing and ensuring patients around the world have access to our innovative medicines.” He cited Ohio’s advantageous business climate, skilled workforce, and strategic location as pivotal factors influencing the decision to expand in the region.
This investment reflects Amgen’s strategy to bolster local manufacturing capacities and create job opportunities, reinforcing the company’s long-term commitment to the U.S. market. The expansion not only enhances Amgen’s operational capabilities but also aligns with broader trends in the biotechnology sector, where many companies are increasingly focusing on local production to meet the growing global demand for innovative medical solutions.
With this move, Amgen joins a growing list of companies investing in the U.S., particularly in Ohio, which has become a key destination for biotech and pharmaceutical firms. The state is viewed as an attractive location due to its skilled labor pool and supportive infrastructure, which fosters business growth and innovation.
Overall, Amgen’s $900 million investment underscores the company’s dedication to enhancing its manufacturing operations domestically while simultaneously creating significant employment opportunities in Ohio, marking a positive development for the local economy and the biotechnology industry at large.
The content above is a summary. For more details, see the source article.